Case Western Reserve University/University Hospitals Cleveland Medical Center, Ohio
A tenure track Associate Professor and NIH funded physician-scientist in the Departments of Internal Medicine, Pediatrics, Pathology, and Biochemistry at Case Western University; The Director of the Division of Pulm/CC Basic Science and Translational Critical Care Research and Co-Director for PCCM and the Inaugeral director of the Casae Western and UH Blood, Heart, Lung, and Immunology Research Center.
Previously, Dr. Remy was an Associate Professor at Washington University in St. Louis in Pediatrics and Internal Medicine. Dr. Remy has expertise in adult and pediatric sepsis, COVID disease, and global health.His laboratory is focused on two areas: heme-based trafficking and signaling in immune dysregulation in context of diseases of intravascular hemolysis and real time immunophenotyping to identify timing for immunoadjuvant therapies including COVID. Dur He has been featured on a number of news programs including CNN, CBS Evening News, BBC News, People, NBCnews, speaking on the immunologic consequences of disease,MIS-C, public health measures, and potential therapies. He is the previous chair of the research section for SCCM, the immunology chair for the PALISI network, and holds key leadership positions in many other organizations including executive committee of the research section of SCCM and member at large for the Internal Medicine section of SCCM. He is a fellow in the American College of Critical Care Medicine and the society of Pediatric Research. MD from Jefferson Medical College, Masters’ Degrees from Duke University and Wash U (Immunology). Dual residencies in Internal Medicine and Pediatrics at CWRU, Pediatric Critical Care fellowship at Columbia University, and Adult Critical Care Fellowship at the NIH.
High-Frequency Debriefing Enhances Perceived Working Conditions Among Residents in the Pediatric ICU
Sunday, March 22, 2026
11:00 AM - 12:00 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Targeting DPP3: A New Frontier in Sepsis Management
Sunday, March 22, 2026
12:20 PM - 12:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Review of Clinical and Epidemiologic Research
Sunday, March 22, 2026
4:50 PM - 5:05 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Comparative Effectiveness of Protocolized Sepsis Care in Neonatal and Pediatric Intensive Care Units
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Phoenix Sepsis Score in Low-Resource Settings: Proposed Modified Criteria From Global PARITY Cohort
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
High-Fiber Diet Favorably Influences Innate and Adaptive Immune Response in a Mouse Model of Sepsis
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Pro/Con: Are Mandatory Vaccinations for Critical Care Workers Effective?
Monday, March 23, 2026
11:00 AM - 12:00 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Hematological Parameters as Prognostic Biomarkers for Sepsis and Malaria in Resource-Limited Setting
Monday, March 23, 2026
11:30 AM - 12:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Rising Use of Immune Modulators in Pediatric Sepsis: Insights From an 8-Year PHIS Database Study
Monday, March 23, 2026
11:30 AM - 12:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Advancing Sepsis Diagnostics: Implementing Novel Biomarkers and Technologies in the ED and ICU
Monday, March 23, 2026
1:30 PM - 2:15 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Heme and Cell-Free Hemoglobin Drive RBC-Endothelial Adhesion in Critical Illness
Tuesday, March 24, 2026
8:45 AM - 9:45 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Epidemiology of Children With Acute Neurologic Dysfunction in Resource-Constrained Settings
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Achieving High-Quality Congenital Heart Surgery Outcomes in Resource-Constrained Settings
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Recognizing Common Immunologic Emergencies.
Tuesday, March 24, 2026
2:35 PM - 2:50 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
CAR-T and BIT Therapies Explained
Tuesday, March 24, 2026
2:50 PM - 3:05 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.